Company attributes
Other attributes
FoRx Therapeutics is a biotechnology company that is developing a drug discovery platform for cancer drugs. The company is backed by a syndicate of investors that include the Novartis Venture Fund, Pfizer Ventures, M Ventures, Omega Funds and LSP Venture Capital.
FoRx Therapeutics is focused on drugging key molecular targets that are involved in the DNA Replication Stress, as a new approach in developing targeted anticancer drugs.
FoRx scientists have more than 20 years of experience in DNA replication stress and DNA Damage Response pathways. Its team comprises of scientists and advisors who have experience in biochemistry, cancer biology, cancer genomics, medicinal chemistry and small molecule drug discovery.